The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

Phase: PHASE2 | Sponsor: Yale University | Compound: Psilocybin

Status

planned

Institution

Yale University

Start date

2026-05-01

End date

2030-05-01

Registry ID

NCT07610369

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.